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Abstract
Background: Psychophysiological processing has been reported to play a crucial role in irritable
bowel syndrome (IBS) but there has been no report on modulation of the stress marker
chromogranin A (CgA) resulting from muscle stretching. We hypothesized that abdominal muscle
stretching as a passive operation would have a beneficial effect on a biochemical index of the activity
of the sympathetic/adrenomedullary system (salivary CgA) and anxiety.
Methods: Fifteen control and eighteen untreated IBS subjects underwent experimental abdominal
muscle stretching for 4 min. Subjects relaxed in a supine position with their knees fully flexed while
their pelvic and trunk rotation was passively and slowly moved from 0 degrees of abdominal
rotation to about 90 degrees or the point where the subject reported feeling discomfort.
Changes in the Gastrointestinal Symptoms Rating Scale (GSRS), State Trait Anxiety Inventory
(STAI), Self-rating Depression Scale (SDS), ordinate scale and salivary CgA levels were compared
between controls and IBS subjects before and after stretching. A three-factor analysis of variance
(ANOVA) with period (before vs. after) as the within-subject factor and group (IBS vs. Control),
and sex (men vs. female) as the between-subject factors was carried out on salivary CgA.
Results: CgA showed significant interactions between period and groups (F[1, 31] = 4.89, p =
0.03), and between groups and sex (F[1, 31] = 4.73, p = 0.03). Interactions between period and sex
of CgA secretion were not shown (F[1, 3] = 2.60, p = 0.12). At the baseline, salivary CgA in IBS
subjects (36.7 ± 5.9 pmol/mg) was significantly higher than in controls (19.9 ± 5.5 pmol/mg, p <
0.05). After the stretching, salivary CgA significantly decreased in the IBS group (25.5 ± 4.5 pmol/
mg), and this value did not differ from that in controls (18.6 ± 3.9 pmol/mg).
Conclusion: Our results suggest the possibility of improving IBS pathophysiology by passive
abdominal muscle stretching as indicated by CgA, a biochemical index of the activity of the
sympathetic/adrenomedullary system.
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Background
Paying attention to the gut may magnify perceptions of
abdominal symptoms and symptom related emotion
[1,2]. Irritable bowel syndrome (IBS) is associated with an
increased incidence of psychological disorder in patient
populations [3], and while the cause and nature of this
association are a matter of discussion, several possible
mechanisms, both psychological and physiological, have
been proposed to account for the finding [4-6]. Although
there are many treatment strategies [7], traditional IBS
therapy is mainly symptom oriented and often unsatisfac-
tory. Increasing knowledge of brain-gut physiology [8],
mechanisms, and neurotransmitters and receptors [9]
involved in gastrointestinal motor and sensory function
have led to the development of several new therapeutic
approaches [10,11].
No single medication has proven to be universally effec-
tive, and the multiple therapeutic approach of gastrointes-
tinal neurophysiology has led to promising advances in
medical and non-medical approaches to IBS. Most studies
have examined the association between mood state and
IBS symptom severity using between-subjects design. The
mechanisms involved suggest an association between
mood state and IBS symptom severity within the individ-
ual. For example, although self-report measures of symp-
tom severity cannot distinguish between the effect of
mood state on physiology and on symptom perception,
both mechanisms would lead to a situation in which a
worsening of mood would occur before a worsening of
IBS symptoms when both are measured longitudinally.
Autonomic imbalance has been proposed as a pathophys-
iological factor of IBS. Adrenergic neural activity and rec-
tal sensitivity are more pronounced in IBS patients than in
normal controls [12]. The stress response system includes
the sympathetic/adrenomedullary (S/A) system and the
hypothalamic-pituitary-adrenal (HPA) axis. The activities
of the HPA axis and the S/A system can be biochemically
evaluated by measuring catecholamines and cortisol, and
we can measure these hormones as objective markers of
stress. Recently, as a result of investigating the derivatives
of catecholamines that are detectable in saliva, chrom-
ogranin A (CgA) was determined to be a useful index of
psychological stress. CgA is a member of a family of highly
acidic proteins, chromogranins, which are co-stored in the
adrenergic neurons and paraneurons and co-released with
adrenaline and noradrenaline in response to stimulation
[13,14]. The changes in salivary CgA secretion resulting
from exposure to a cognitive task may indicate psycholog-
ical stress in humans [15].
Colonic stimulation results in brain activation of the som-
atosensory, insular, anterior cingulate and prefrontal cor-
tices [2]. The somatosensory cortex receives direct
anatomical projections from the ventral posterior tha-
lamic nucleus, it is generally assumed that the somatosen-
sory cortex is involved in parallel processing of tactile
sensory information derived from this thalamic source of
input [16]. In contrast, psychological stress influences
pain thresholds via activation of the prefrontal cortices.
Corticotropin releasing hormone is released from the
hypothalamus, binding to visceral muscles and causing
abnormal movement of the colon [9,17]. A stress marker
of the S/A system, CgA, is released in saliva due to negative
feelings such as aversive stimuli and psychological stress
[15,18]. Mental activity may modulate gut perception
[18,19] and override the effect of somatic stimulation on
gut perception. For example, afferent signals from muscle
stretching might modulate visceral perception and emo-
tion via the spinothalamic pathway.
Skeletal muscle stretching is a unique method for relaxa-
tion [20-22]. The effect of hypnotherapy on IBS has been
well documented [23], but specific psychotherapy usually
needs long-range training for therapists at much cost. On
the other hand, skeletal muscle stretching is simple and
applicable in daily practice. Skeletal muscle stretching
improved subjective pain scores of the patients with low
back pain, and salivary cortisol concentrations were also
significantly decreased during exercise [24]. However, the
effects of skeletal muscle stretching on IBS are still
unknown.
We hypothesized that IBS subjects would show abnormal
salivary CgA and that skeletal muscle stretching would
have beneficial effects on the pathophysiology of IBS.
Methods
Subjects
This study was approved by the Ethics Committee of Nii-
gata University of Health and Welfare. All subjects gave
their written informed consent. The subjects were univer-
sity students, including 15 healthy volunteers as controls
(7 males, 8 females: university students at Niigata Univer-
sity of Health and Welfare) and 18 subjects with IBS (not
receiving medical treatment for IBS, 7 males, 11 females)
aged 20 to 23 years old. The IBS subjects were 20 subjects
selected from 245 volunteers selected through a pre-
designed questionnaire based on the Rome III criteria [25]
for functional gastrointestinal diseases. Two IBS subjects
were excluded from the results because of incomplete
examinations due to cold and headache.
As recommended by the Rome III committees [25],
patients with IBS were classified by the predominant stool
pattern: IBS with diarrhea (IBS-D) was defined as loose
(mushy) or watery stool >25% and hard or lumpy stool
<25% of bowel movements; and IBS with constipation
(IBS-C) as hard or lumpy stool 25% and loose or wateryBioPsychoSocial Medicine 2008, 2:20 http://www.bpsmedicine.com/content/2/1/20
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stool <25% of bowel movements. Based on questions
about the proportion of bowel movements that were
either loose or watery, or hard or like a ball (lumpy), IBS
subjects were classified by Rome III criteria [25] as IBS-D
(n = 4), IBS-C (n = 8), IBS-M (n = 2) and IBS-U (n = 4).
Stretching of the abdominal muscles
Subjects attended a preliminary test session that included
the measurement of psychological characteristics and
maximal abdominal muscle stretch. Subjects relaxed in a
supine position with their knees fully flexed while their
pelvis and trunk were passively and slowly moved from 0
degrees of abdominal rotation to about 90 degrees or
until the subject reported feeling discomfort.
Participants attended one of several 30-minute experi-
mental stretch sessions that were conducted at the same
time of day. Subjects were instructed not to begin a
stretching program session and to reschedule their ses-
sion, if symptoms of their IBS prevented the stretching.
During the session, subjects engaged in a 1-minute cyclic
stretching protocol, 2 times right and left side rotation of
their pelvis and trunk, and a 4-minute static stretching
protocol. For the 4-minute static stretching protocol, the
subject's knees were moved at a rate of 30°/s from 90
degrees of trunk and pelvic rotation (neutral) to a static
hold at 80% of the subject's maximal passive rotation
angle for one minute [26]. Immediately following the
static stretching, the knees were returned to neutral, then
moved to 80% of maximal angle on the other side, and
again returned back to neutral [27]. The last stretching
sequence was necessary so that measurements of stiffness
and abdominal discomfort before the stretching could be
compared with measurements of sensation and emotion
after the stretching.
Measurement of symptoms and psychological status
Before the experiment, gastrointestinal (GI) symptoms
and psychological status were evaluated using the Gas-
trointestinal Symptoms Rating Scale (GSRS) [28], Zung's
Self-rating Depression Scale (SDS) [29], and the State-
Trait Anxiety Inventory (STAI) [30]. In addition, the sub-
jects were asked to report the following seven items of vis-
ceral sensation or emotion [2]: abdominal discomfort,
abdominal distention, abdominal pain, urgency for defe-
cation, perceived stress, sleepiness, and anxiety before and
after perceived stretching. Each sensation was evaluated
on a scale from 0 (no sensation) to 10 (maximal sensa-
tion) as previously described [2,31].
GSRS is a 15-item instrument designed to assess the symp-
toms associated with common GI disorders. It has five
subscales (Reflux, Diarrhea, Constipation, Abdominal
Pain, and Indigestion Syndrome). Subscale scores range
from 1 to 7 and higher scores represent more discomfort.
A total score is derived by summing the individual item
scores, and ranges from 15 to 105 [32].
SDS is a 20-item self-report questionnaire. Each item is
scored on a Likert scale ranging from 1 to 4. A total score
ranges from 20 to 80. Most people with depression score
between 50 and 69, while a score of 70 and above indi-
cates severe depression [33].
Mean scores of STAI for normal subjects were substan-
tially lower than those reported in the English STAI Man-
ual (State 24.95 ± 11.36 vs. 36.54 ± 10.22 and the Trait
score was 27.88 ± 11.43 vs. 35.55 ± 9.76). The reported
scores for depressed patients were 56.22 ± 8.86 and 53.83
± 10.87, The state score for healthy subjects was 34.30 ±
10.79 and the Trait score was 36.07 ± 10.47 [34].
Salivary CgA sampling
Salivary samples were collected immediately before and
after stretching. Saliva samples were extracted from cotton
wads that subjects held in their mouths for 2 min by cen-
trifuging at 3,000 rpm for 15 min. The tactile stimulation
of the presence of the cotton wad in the oral cavity tends
to stimulate a rather uniform salivary flow [35]. During
collection, the cotton wad was rolled around like a hard
candy in the oral cavity. The samples were stored at -20°C
until the assay. Salivary CgA levels were determined using
an enzyme-linked immunosorbent assay (EIA) kit (YK070
Human Chromogranin A EIA, Yanaihara Institute, Inc.,
Shizuoka, Japan), using the method of Yanaihara et al.
[36] of Yanaihara Laboratories (Fujinomiya, Shizuoka,
Japan). The corrected values of CgA (pmol/mg) were cal-
culated by dividing by the raw results of EIA with the pro-
tein concentration of the saliva in the samples (pg/mg).
Levels of salivary CgA were evaluated, according to a pre-
viously described method [35,37,38]. Salivary CgA levels
are reported as being within the range of 50.0 ± 40.0
pmol/mg (protein corrected) in healthy subjects [39]. Sal-
ivary CgA might be a sensitive and promising index for
psychosomatic stress. Therefore, an understanding of the
circadian rhythm of salivary CgA in normal humans is
important. According to a recent report, CgA does not
show any obvious circadian rhythm. Salivary CgA levels
peak upon awakening, and then quickly decrease to the
nadir after 1 hour and maintain a low level throughout
the day [40]. The circadian variation of CgA is still not
fully established.
Statistic analysis
A three-factor analysis of variance (ANOVA) with period
(before vs. after) as the within-subject factor and group
(IBS vs. Normal) and sex (men vs. female) as the between-
subject factors, was carried out on salivary CgA. Changes
in revised salivary CgA levels between before and afterBioPsychoSocial Medicine 2008, 2:20 http://www.bpsmedicine.com/content/2/1/20
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stretching sessions for each group were analyzed statisti-
cally by related-measures 3-factor ANOVA, followed by
Bonferroni protected least significant difference for multi-
ple comparisons; values of p < 0.05 were considered sig-
nificant.
Values of visceral perception and emotion were compared
between groups with the Mann-Whitney U test. Spear-
man's rank correlation was used for evaluating the intra-
group correlation coefficient between CgA and
psychological status and perceptional/emotional ratings;
values of p < 0.05 were accepted as significant.
Results
GI symptoms and psychological status
Table 1 shows the scores for GI symptoms and psycholog-
ical status in the Normal and IBS groups. The GSRS score
of IBS subjects was significantly higher than that of Nor-
mal subjects (Mann-Whitney's U test, p = 0.01). State anx-
iety and trait anxiety scores of STAI of IBS subjects were
significantly higher than those of normal subjects (p <
0.01). SDS scores did not significantly differ between Nor-
mal and IBS subjects.
Abdominal discomfort in IBS subjects before and after
stretching was significantly higher than in Normal sub-
jects (p = 0.03) (Table 2). After stretching, there was no
difference in abdominal discomfort between the groups.
Anxiety was significantly decreased by stretching in Nor-
mal subjects (p = 0.04).
Two-way ANOVA of abdominal discomfort showed that
there were significant period × group interactions (F [3,
62] = 6.82, p = 0.005). Before stretching, abdominal dis-
comfort in IBS subjects (1.84 ± 0.43) was significantly
higher than in Normal subjects (0.27 ± 0.12, post-hoc, p
= 0.02). After stretching, abdominal discomfort in IBS
subjects (1.74 ± 0.37) was significantly higher than in
Normal subjects (0.20 ± 0.11, post-hoc, p = 0.01).
Abdominal discomfort changes between before and after
stretching in Normal controls were not significant (post-
hoc, p = 0.89). There were no changes in the other scales
before and after stretching or between normal controls
and IBS subjects.
Changes of salivary CgA
For multiple group comparisons, homogeneity of vari-
ance was assessed by the Levene test. Three-way repeated-
measures ANOVA of CgA showed significant interactions
between period and groups (F[1, 31] = 4.89, p = 0.03),
and between groups and sex (F[1, 31] = 4.73, p = 0.03).
Interactions between period and sex of CgA secretion were
not significant (F[1, 3] 2.60, p = 0.12). Before stretching,
salivary CgA in IBS subjects (36.7 ± 5.9 pmol/mg) was sig-
nificantly higher than in Normal subjects (19.9 ± 5.5
pmol/mg, post-hoc, p = 0.006) (Fig. 1). CgA changes
before and after stretching in Normal subjects were not
significant (post-hoc, p = 0.60). In contrast, CgA was sig-
nificantly decreased after stretching in IBS subjects (22.5 ±
4.5 pmol/mg, post-hoc, p = 0.02). After stretching, there
was no significant difference in CgA between Normal and
IBS subjects (post-hoc, p = 0.22).
The Spearman rank correlation coefficient showed a sig-
nificantly positive correlation between CgA secretion
before stretching and SDS score in IBS (r = 0.51, p = 0.03)
(Table 3). The change in CgA after stretching compared
with before stretching was positively correlated to the SDS
score in both groups (IBS: r = 0.52, p = 0.03. Normal: r =
0.53, p = 0.04). In ratings of perception and emotion, per-
ceived stress to stretching was negatively correlated with
CgA secretion in the Normal group (r = -0.66, p = 0.007).
Discussion
This is the first study to demonstrate that the salivary CgA
level of IBS subjects is higher than that of normal subjects.
We also demonstrated that, after stretching, the CgA level
of IBS subjects became comparable with that of normal
subjects. CgA is a major soluble protein in adrenal medul-
lary chromaffin granules and adrenergic neurons and is
co-released with catecholamines, which are considered to
be a good index of sympathetic activity [41,42]. In partic-
ular, salivary CgA is reported to be a sensitive and substan-
tial marker of psychological stress, which does not
respond well to physical stress [15]. The results of this
study suggest that abdominal muscle stretching may
improve sympathetic arousal in IBS subjects.
Patients with IBS show more psychiatric disorders and
pathologic behavioral patterns than normal subjects
[4,43]. A correlation between CgA secretion and the
depression score was observed in this study. This result
suggests a potential mechanism connecting events in the
nervous system (central or enteric) with IBS symptoms.
Noradrenaline in the brain plays a crucial role in anxiety,
and colorectal distention induces noradrenaline release in
the hippocampus [44]. Not only central but also periph-
Table 1: Comparisons of GI symptoms and psychological status 
between IBS subjects and normal controls
Controls (n = 15) IBS (n = 18) p
GSRS 32.47 ± 5.21 51.16 ± 4.95* <0.01
STAI-S 23.20 ± 3.23 41.90 ± 1.62* <0.01
STAI-T 25.53 ± 3.22 42.53 ± 1.80* <0.01
SDS 42.00 ± 1.60 45.21 ± 1.73 0.23
Mean ± Standard Error. *Comparison between normal group vs. IBS 
group by the Mann-Whitney's U test. GSRS: Gastrointestinal 
Symptoms Rating Scale, STAI-S: state anxiety, STAI-T: trait anxiety, 
SDS: Self-rating Depression Scale.BioPsychoSocial Medicine 2008, 2:20 http://www.bpsmedicine.com/content/2/1/20
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eral adrenergic/noradrenergic functions may contribute to
the pathophysiology of IBS. Elsenbruch et al. reported
that IBS patients demonstrated significantly greater post-
prandial increases in plasma noradrenaline and systolic
blood pressure [45]. In inflammatory bowel diseases, dis-
turbed adrenergic regulation of interleukin-10 (IL-10)
could be part of the mechanism underlying the modula-
tion of disease activity due to psychological stress [46].
Disturbed autonomic or neuroendocrine modulation of
cytokine production, may play a role in the pathogenesis
of IBS [9]. Increased salivary CgA in IBS subjects suggests
that IBS subjects have sympathetic arousal due to
increased signaling to the gut afferent neurons.
IBS symptoms are generally worsened by stress and often
improve with physical exercise and medications affecting
serotonin function [47-49]. Sugano et al. reported that the
skeletal muscle stretching program improved subjective
pain scores of the patients with low back pain and that sal-
ivary cortisol concentrations were also significantly
decreased up to 90 min after exercise [24]. Exercise may
have beneficial effects on IBS symptoms [50].
CgA secretion before stretching was negatively correlated
with the stress score of normal subjects. Additionally, the
anxiety score was reduced after stretching in the normal
subjects. Psychological factors influencing symptom
reporting have been identified in the constructs of visceral
perceptional amplification and alexithymia [51]. From a
psychological viewpoint, IBS may be conceived as an
abnormal cognitive processing of emotional stimuli, via
verbal responses, and a tendency to perceive somatic stim-
uli as evidence of symptoms of disease.
Ghoncheh et al. examined the psychological and physical
effect of passive muscle stretching and yoga stretching
exercises for relaxation [22]. Muscle relaxation displayed
higher levels of relaxation states, physical relaxation, dis-
engagement and higher levels of joy as a post-training
effect [52]. Muscle stretching provides sensation contrasts
for learning relaxation in addition to fostering relaxation
through the stretching of muscles [53]. Muscle stretching
for patients with IBS may be of benefit to the patients and
could be used as part of a multi-component approach to
the treatment of IBS.
Evidence of a physiological component of IBS is based on
gender differences in GI symptoms, central nervous sys-
tem pain processing, and specific effects of estrogen and
progesterone on gut function [54,55]. Additional factors
may play a role, including gender-related differences in
neuroendocrine, S/A system, and stress reactivity, which
Table 2: Ratings of perception and emotion
Perception and emotion Normal (n = 15) IBS (n = 18)
Before After Before After
Abdominal discomfort 0.27 ± 0.12 0.20 ± 0.11 1.84 ± 0.43*a 1.74 ± 0.37*b
Abdominal distention 0.40 ± 0.16 0.40 ± 0.16 1.32 ± 0.39 1.05 ± 0.35
Abdominal pain 0.20 ± 0.11 0.27 ± 0.15 0.74 ± 0.30 0.47 ± 0.25
Urgency 0.33 ± 0.16 0.47 ± 0.19 0.32 ± 0.23 0.26 ± 0.19
Stress 2.40 ± 0.54 2.27 ± 0.57 2.21 ± 0.41 2.37 ± 0.50
Sleepiness 3.00 ± 0.39 3.53 ± 0.45 4.42 ± 0.72 5.00 ± 0.64
Anxiety 2.20 ± 0.48 0.87 ± 0.35*c 2.42 ± 0.47 1.90 ± 0.48
Mean ± Standard Error. *a: Comparison between Normal group vs. IBS group before stretching (p = 0.03), *b: Normal group vs. IBS group after 
stretching (p = 0.03), *c: before vs. after stretching of the Normal group (p = 0.04) by Mann-Whitney's U test.
Table 3: Correlation between (r) CgA and GI symptoms and psychological status before and after stretching for the Normal and IBS 
groups.
GSRS SDS STAI-S STAI-T Abdominal Discomfort Abdominal Pain Stress Anxiety
IBS (n = 18)
before -0.16 0.51* -0.17 -0.30 0.11 -0.13 -0.20 0.05
after -0.34 0.19 -0.41 -0.29 0.24 -0.20 -0.37 -0.21
ΔCgA 0.08 0.52* 0.04 0.09 0.10 -0.05 0.18 0.36
Normal (n = 15)
before 0.07 0.24 0.16 0.44 -0.23 0.13 -0.53* -0.01
after -0.20 0.08 0.15 0.07 -0.36 -0.04 0.09 0.18
ΔCgA 0.26 0.53* -0.01 0.40 0.09 0.25 -0.66* 0.04
Significance, *p < 0.05. ΔCgA: CgA secretion before stretching – CgA after stretching.BioPsychoSocial Medicine 2008, 2:20 http://www.bpsmedicine.com/content/2/1/20
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are related to bowel function and pain. Although gender
differences in the therapeutic benefits of serotonergic
agents have been observed [56], less is known about
potential differences in responsiveness to non-drug thera-
pies for IBS. Multiple comparisons between CgA and gen-
der related information suggest that stretch intervention
may have gender dependent effects on IBS.
The following three points can be cited as limitations of
this study. The first is that sample size was very small. The
levels of CgA found in our subjects were somewhat differ-
ent from the reported mean value [39], and our findings
could not exclude the effect of the sample size. Addition-
ally, we could not examine the effects on subtypes of IBS
(i.e. constipation-predominant or diarrhea-predomi-
nant), because the sample sizes of the subtypes were too
small to analyze them separately. However, a long follow-
up study [57] proved the inconsistency of IBS subtypes,
suggesting that whole IBS analysis is more important than
subtype analysis. The second limitation is that the dura-
tion of muscle stretching might be too short. The duration
of the effect of contraction-relaxation stretching on range
of motion (ROM) in the lower extremities is 15 min and
the increase in ROM usually remains for 90 min [58]. Pro-
prioceptive neuromuscular facilitation (PNF) stretching
techniques produced greater increases in ROM than static
or dynamic stretching exercises. The stretching hold time
at the hip is 3–10 sec in one hold-relax PNF stretch [59].
There is no study that clarifies the stretch duration
required of the abdominal muscle for relaxation. Thus, it
will be necessary to examine how long we should stretch
the abdominal muscles for IBS treatment. Lastly, we could
not analyze the effect of lifestyle and medical history on
CgA in this study. Many stress-related biomarkers are
affected by lifestyle or medical history [60]. Such relation-
ships might contribute to increased knowledge about
strategies to prevent progression of IBS.
Conclusion
Our results suggested that it is possible to improve IBS
pathophysiology by passive abdominal muscle stretching
using a biochemical index of the activity of the S/A system
(salivary CgA). In this study, we verified only the effects of
stretching and presence of IBS on CgA levels. Further study
of the S/A system and muscle stretching in IBS is war-
ranted.
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